Strategic Advocates’s PACS Group PACS Stock Holding History

Strategic Advocates’s Portfolio PACS Stock Details PACS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,182	Closed	-$203K	–	641
2025 Q4	$203K	Buy	5,182 +808	+18%	+$17.7K	0.05%	114
2025 Q3	$60.1K	Buy	+4,374	New	+$51.3K	0.02%	191

Other funds holding PACS

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Crewe Advisors Salt Lake City, Utah $1.17B AUM 29.21% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Strategic Advocates's PACS Position: Q1 2026 in Review

Strategic Advocates sold out of PACS Group (PACS) in Q1 2026, closing a stake of 5,182 shares — an estimated $203K sold.

Strategic Advocates first reported a position in PACS in Q3 2025 and held it in 2 quarters. The position peaked at $203K in Q4 2025. 215 funds tracked by Wall St. Rank hold PACS as of Q1 2026.

Strategic Advocates reported no remaining PACS Group position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 5,182 PACS Group shares in Q1 2026, an estimated $203K.
Strategic Advocates first reported a position in PACS Group in Q3 2025 and held it in 2 quarters.
Strategic Advocates's PACS Group position peaked at $203K in Q4 2025.
215 funds tracked by Wall St. Rank held PACS Group as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.